Home›Voriconazole›Voriconazole + Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen

Does Voriconazole Interact with Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen?

CDI records a unknown classification for Voriconazole and Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen. The stored summary is: Azole Antifungal Agents: fluconazole itraconazole ketoconazole posaconazole voriconazole ↑ RPV , This interaction study has been performed with a dose higher than the recommended dose for RPV. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Unknown
Voriconazole Class
Azole Antifungal
Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen Class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Voriconazole and your doctor is considering prescribing Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Voriconazole(Vfend)+💊 Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen(Odefsey)

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The CDI record includes an interaction but its severity has not been classified.
Severity scale
MinorContra
On record
Yes
Drug A class
Azole Antifungal
Drug B class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Source
FDA drug label - emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide

What this means in plain English

Azole Antifungal Agents: fluconazole itraconazole ketoconazole posaconazole voriconazole ↑ RPV , This interaction study has been performed with a dose higher than the recommended dose for RPV.

About Voriconazole and Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen

Voriconazole is an Azole Antifungal, while Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen is a Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor. You may recognize them by the brand names Vfend and Odefsey. Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: FDA drug label - emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Voriconazole and Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations